A ‘strict but permissive approach’: A case study of UK regulation of human-tissue and cell therapies
While the developments in European regulation described in the previous chapter provide an important context for, and framing of, international regulatory policy relating to regenerative medicine and the new tissue-and cell-based therapies, national (political) culture and history can also be seen as significant, as we have seen. The United Kingdom has had a high profile in this international arena and, some have argued, has sought to lead debate. This chapter provides a closer analysis of the dynamics of policy-making at the national level and reflects on what might be the specific features of the UK approach to regulating these technologies. At the same time, I want to examine how the recent policy developments in Europe have been played out and implemented in the United Kingdom.